Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Generic Reglan and Zofran Recall By Hospira Due to Glass Particles October 3, 2013 Irvin Jackson Add Your Comments Hospira, Inc. is recalling one lot of generic Reglan and two lots of generic Zofran, after injectable versions of the drugs were found to contain strands of glass. The generic Reglan and generic Zofran recall was announced by the FDA on October 1, after glass particles were found affixed to the inside of vials. Although there have been no reports of adverse events or injuries related to the recall, Hospira warns that the strands could become dislodged in the vials and beinjected into a patient. That could result in local inflammation, allergic reactions, and thrombophlebitis. Learn More About Zofran Lawsuits Use of Zofran in Pregnancy May Increase the Risk that Children Suffer Cleft Palate, Cleft Lip, Heart Defects or Other Malformations. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Zofran Lawsuits Use of Zofran in Pregnancy May Increase the Risk that Children Suffer Cleft Palate, Cleft Lip, Heart Defects or Other Malformations. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Symptoms of problems would include redness, pain, swelling at the injection site, fever, shortness of breath, tachycardia, as well as nausea and vomiting. The particles could also cause an embolism that could be particularly dangerous to the elderly, children, patients with compromised immune systems, and micro or macrovascular disease. The recall affects one lot of Metoclopramide Injection, USP, 10 mg/2 mL (5 mg/mL), NDC 0409-3414-01, Lot 28-104-DK. They were packaged in 2 mL single-dose fliptop vials, with an expiration date of October 1, 2014. It also affects two lots of Ondansetron Injection, USP, 4 mg/2 mL (2 mg/mL), NDC 0409-4755-03, Lots 29-484-DK and 29-510-DK. They were packaged in 2 mL, single-dose fliptop vials, with an expiration date of May 1, 2015. Both were packaged in 25-unit cartons and 100 units per case. All three lot numbers may be followed by a -01. The lots affected by the recall were distributed nationwide between June 2013 and September 2013. Reglan and Zofran Side Effects Reglan is approved for the short-term treatment of gastrointestinal disorders, such as diabetic gastroparesis, gastroesphageal reflux (GERD) and delayed gastric emptying. However, it has often been prescribed for longer periods of time due to the often chronic persistence of those ailments. The drug is now available only as generic metoclopramide. Side effects of Reglan have been linked to neurological problems, including a rare movement disorder known as tardive dyskinesia, which may sometimes leave patients with permanent problems that continue even after the medication is no longer used. In the United States, the FDA required the manufacturers of all medications containing metoclopramide to update the warning label in February 2009, providing information that users may face an increased risk of tardive dyskinesia when the medications are used at high doses or for a long period of time. Symptoms of tardive dyskinesia can include grimacing, chewing, smacking of lips, rapid eye movements and impaired finger movements. There is no known effective treatment of the socially debilitating disorder, and the involuntary movements can be permanent, persisting even after use of the drug has stopped. Generic Zofran (ondansetron) is a member of a class of drugs known as 5-HT3 receptor antagonists, which work by blocking the actions of serotonin. It is commonly used for treatment of nausea caused by cancer treatments, but it has been widely used among pregnant women suffering from morning sickness, even though the FDA has not approved it for that use. About 10% of pregnant women suffer from nausea severe enough that doctors recommend they take anti-nausea medication. However, at least one study has raised concerns that Zofran could cross the placenta and adversely affect their child’s development or health. The study suggested that the drug could increase the risk of oral cleft birth defects, such as cleft palate and cleft lip. Known side effects of Zofran have been linked to a risk of a type of irregular heart rhythm, known as QT interval prolongation. This may predispose patients to develop Torsades de Pointes, which may lead to sudden death if proper treatment is not received. In December 2012, the FDA announced a partial Zofran recall because of the heart rhythm problems associated with the drug. The recall only affects the 32 mg, single intravenous (IV) dose, which is usually used to prevent chemotherapy-induced nausea and vomiting. Tags: Birth Defects, Hospira, Metoclopramide, Particulate Matter, Reglan, Tardive Dyskinesia, Zofran Image Credit: | More Zofran Lawsuit Stories Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit January 10, 2023 Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption June 7, 2021 First Bellwether Trial Over Zofran Birth Defects Set To Begin October 2021 March 5, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025) Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025) Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)
Trial Court Dismissal of Zofran Birth Defect Lawsuits Upheld on Appeal Before First Circuit January 10, 2023
Birth Defect Lawsuits Over Zofran Dismissed After Summary Judgment Granted on Federal Preemption June 7, 2021
Hair Relaxer Settlement Master Appointed To Oversee Negotiations To Resolve Cancer Lawsuits (Posted: today) A federal judge has appointed a special master to help parties involved in hair relaxer lawsuits potentially negotiate a settlement to resolve the litigation. MORE ABOUT: HAIR RELAXER LAWSUITHair Relaxer Lawyers To Meet With MDL Judge Amid “Contentious” Disputes Over Bellwether Discovery Plans (04/23/2025)More Than 12,000 Hair Relaxer Cancer Lawsuits Filed Against L’Oreal, Other Cosmetics Companies (04/17/2025)Uterine and Endometrial Cancer Caused by Hair Relaxer Products: Lawsuit (03/25/2025)
Additional AFFF Ulcerative Colitis Lawsuits Added to Bellwether Discovery Pool (Posted: today) A federal judge has added three additional ulcerative colitis claims to a pool of AFFF lawsuits being prepared for early test trials. MORE ABOUT: AFFF LAWSUITFirefighter Unions File Class Action Lawsuit Over Cancer-Causing Chemicals in Protective Gear (04/25/2025)Pennsylvania Residents File Class Action Lawsuit Over Jet Fuel Pipeline Leak (03/31/2025)Apple Watch PFAS Lawsuit Alleges Toxic Chemicals in Wrist Bands Could Increase Cancer Risks (03/14/2025)
Ozempic Blindness Lawsuit Claims Drug Caused NAION Side Effects (Posted: yesterday) A new lawsuit claims that the diabetes and weight loss drug, Ozempic, caused a woman to lose vision in her left eye. MORE ABOUT: OZEMPIC LAWSUITOzempic-Related Emergency Room Visits Are Often Caused by Gastrointestinal Issues: Study (04/23/2025)Ozempic Side Effects Caused Stomach Paralysis and Severe Abdominal Pain, Lawsuit Claims (04/18/2025)Ozempic Gastroparesis Lawsuit Filed Over Nausea, Severe Abdominal Pain (04/04/2025)